IMPRIMIS PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • April 26th, 2016 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), is made and entered into as of April 25, 2016, by and between Mark L. Baum (“Executive”) and Imprimis Pharmaceuticals, Inc. (the “Company”).
IMPRIMIS PHARMACEUTICALS, INC. AMENDED AND RESTATED 2007 INCENTIVE STOCK AND AWARDS PLAN PERFORMANCE STOCK UNITS AGREEMENTPerformance Stock Units Agreement • April 26th, 2016 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Effective as of April 25, 2016 (the “Grant Date”), Imprimis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), has awarded to Andrew R. Boll (“Grantee”) a targeted number of 157,500 Performance Stock Units (the “Performance Stock Units” or “Award”) to be calculated and determined as discussed below. Each Performance Stock Unit will represent an unfunded and unsecured promise of the Company to deliver shares of common stock, par value $0.01 per share, of the Company (the “Shares”) to Grantee as set forth herein. Each Performance Stock Unit will be subject to forfeiture until the date such Performance Stock Unit vests pursuant to Section 1 of this Performance Stock Units Agreement (this “Agreement”). The Performance Stock Units have been granted pursuant to the Imprimis Pharmaceuticals, Inc. Amended and Restated 2007 Incentive Stock and Awards Plan (the “Plan”), and shall be subject to all provisions of the Plan, which are incorporated herein by reference, and of this Agreeme
